Avinger (AVGR) Reports Q4 Revenue of $2.4M, Net Loss of $5M
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Plug Power COO resigns to join another company
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
Avinger Reports Fourth Quarter and Year End 2021 Results
March 22, 2022 4:02 PM EDTREDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Avinger, Inc. (NASDAQ: AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the fourth quarter and full year ended December 31, 2021.
Financial and Recent Highlights
Full year 2021 revenue of $10.1 million, an increase of 16% from the prior yearFourth quarter revenue of $2.4 million, reflecting the impact of Omicron variant surge and hospital staffing shortages on procedural volumeFull year gross margin of 34%, increased from 30% in... More